Skip to main content
. 2020 Nov 3;28(2):393–401. doi: 10.1093/jamia/ocaa287

Table 1.

Registries and clinical data networks based on EHR-derived data

Type of Data Resource Benefits Challenges
Disease-based (eg, COVID-19) registry
  • Centralized harmonization and curation of data

  • Easier to manage

  • Specific data items for the disease are harmonized and curated centrally

  • Feasibility of informed consent for use of data

  • Privacy and institutional risks associated with transferring data to a central repository

  • Less transparency on data use

  • Comparisons with other diseases not possible

  • Threat of a single-point-of-failure

  • Labor intensive if each site needs to standardize and curate the data

Clinical data network
  • Typically involves a distributed network of clinics, HPOs and/or research centers

  • Data not restricted to patients with the disease, or to data items directly related to the disease

  • Comparisons with “controls” and with patients with other diseases is possible

  • No single point of failure unless there is dependency on a central hub

  • High number of individuals and records requires additional security and privacy safeguards

  • Detailed, curated data on the disease of interest is not always available

  • Harmonization of complex data elements is hard to coordinate

  • Analytics may require special methods

  • Informed consent may not be feasible

Abbreviation: HPO, health provider organization.